Bittner, Vera A.
Szarek, Michael
Aylward, Philip E.
Bhatt, Deepak L.
Diaz, Rafael
Edelberg, Jay M.
Fras, Zlatko
Goodman, Shaun G.
Halvorsen, Sigrun
Hanotin, Corinne
Harrington, Robert A.
Jukema, J. Wouter
Loizeau, Virginie
Moriarty, Patrick M.
Moryusef, Angèle
Pordy, Robert
Roe, Matthew T.
Sinnaeve, Peter
Tsimikas, Sotirios
Vogel, Robert
White, Harvey D.
Zahger, Doron
Zeiher, Andreas M.
Steg, Ph. Gabriel
Schwartz, Gregory G.
Funding for this research was provided by:
Sanofi
Regeneron Pharmaceuticals
This article is maintained by: Elsevier
Article Title: Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
Journal Title: Journal of the American College of Cardiology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jacc.2019.10.057
Content Type: article
Copyright: © 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.